sulforaphane has been researched along with Prostatic Hyperplasia in 2 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chambers, KF | 1 |
Bacon, JR | 1 |
Kemsley, EK | 1 |
Mills, RD | 1 |
Ball, RY | 1 |
Mithen, RF | 1 |
Traka, MH | 1 |
Myzak, MC | 1 |
Hardin, K | 1 |
Wang, R | 1 |
Dashwood, RH | 1 |
Ho, E | 1 |
2 other studies available for sulforaphane and Prostatic Hyperplasia
Article | Year |
---|---|
Gene expression profile of primary prostate epithelial and stromal cells in response to sulforaphane or iberin exposure.
Topics: Anticarcinogenic Agents; Cells, Cultured; Epithelial Cells; Gene Expression; Gene Expression Profili | 2009 |
Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.
Topics: Androgens; Anticarcinogenic Agents; Apoptosis; Cell Cycle; Epithelial Cells; Histone Deacetylase Inh | 2006 |